Dose/dense metronomic chemotherapy with fractioned cisplatin and oral daily etoposide enhances the anti-angiogenic effects of bevacizumab and has strong antitumor activity in advanced non-small-cell-lung cancer patients.
| Image |  |
|---|---|
| Description | scientific article published on May 2010 |
| Author/s |
author: Salvatore Francesco Carbone Pierfrancesco Tassone Pierosandro Tagliaferri Pierpaolo Correale Michele Caraglia |
| Publication date | May 1, 2010 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |